NCT02346162

Brief Summary

The US obesity epidemic is being transmitted to the next generation. Growing evidence suggests that both a mothers' weight at pregnancy onset, and excessive weight gain during pregnancy, are associated with increased risk of pregnancy-related complications such as gestational diabetes and pre-eclampsia, and an increased risk that her child will become obese and face obesity-related health issues in later life. Currently, over one-third of reproductive-aged women in the U.S. are obese \[body mass index (BMI) ≥ 30\]. Our research team has shown that we can improve birth weight outcomes in babies of obese women who start a weight-management intervention program at 14 to 15 weeks of their pregnancy (soon after their first prenatal visit). However, organogenesis and metabolic programming begin early in the first trimester, well before the first prenatal visit. Therefore, waiting to address mothers' weight, physical activity, and diet quality until the first prenatal visit is not optimal. Given the need to reach overweight and obese women prior to pregnancy, and the Institute of Medicine's (IOM's) recent recommendation, based on observational studies, that women should reach a healthy weight before conceiving, this randomized clinical trial will evaluate a comprehensive preconception weight loss program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
326

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 26, 2015

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2019

Completed
Last Updated

April 5, 2022

Status Verified

April 1, 2022

Enrollment Period

4.1 years

First QC Date

January 20, 2015

Last Update Submit

April 4, 2022

Conditions

Keywords

Pre-pregnancyWeight management

Outcome Measures

Primary Outcomes (1)

  • Reduced pregnancy-related weight gain

    1 day at the end of pregnancy

Secondary Outcomes (2)

  • Lower weight at the start of pregnancy

    Self-reported pre-pregnancy weight supplemented by weight at first prenatal visit (1 day)

  • Decreased risk of exceeding national norms for weight at birth

    birth

Study Arms (2)

Intervention

EXPERIMENTAL

Weight management intervention

Behavioral: Weight management

Usual Care Control

OTHER

Usual Care for planning healthy pregnancy

Other: Usual Care Control

Interventions

Phone counseling for pre-pregnancy weight loss and weight maintenance when BMI \</=25, and when pregnant, weight gain within IOM guidelines.

Intervention

Usual care control participants receive general dietary advice as it relates to planning for a healthy pregnancy (e.g. folate requirements, prenatal vitamins, smoking cessation, alcohol cessation, and prenatal food safety).

Usual Care Control

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Current Kaiser Permanente Northwest (KPNW) member
  • Expects to be KPNW member for at least 2 more years
  • Body Mass Index (BMI) ≥ 27
  • Not currently pregnant
  • Access to computer with Internet
  • Completion of screening diet assessment
  • English speaking

You may not qualify if:

  • Taking medication (insulin or pills) for treatment of diabetes
  • Gastrointestinal disease requiring special diet or medications (for example, ulcerative colitis, celiac sprue, phenylketonuria)
  • Currently receiving treatment for cancer
  • Renal disease (kidney disease requiring special diet or medication)
  • History of bariatric surgery
  • Use of prescription weight loss medications in the last three months
  • Another household member already participating in the Prepare study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anna Edelmann

Portland, Oregon, 97227, United States

Location

Related Publications (3)

  • LeBlanc ES, Smith NX, Vesco KK, Paul IM, Stevens VJ. Weight loss prior to pregnancy and subsequent gestational weight gain: Prepare, a randomized clinical trial. Am J Obstet Gynecol. 2021 Jan;224(1):99.e1-99.e14. doi: 10.1016/j.ajog.2020.07.027. Epub 2020 Jul 18.

  • LeBlanc ES, Boisvert C, Catlin C, Lee MH, Smith N, Vesco KK, Savage J, Mitchell DC, Gruss I, Stevens VJ. Prepare randomized clinical trial: Acceptability, engagement, and lifestyle effects of a weight loss intervention beginning in pre-pregnancy. Obes Sci Pract. 2022 Feb 24;8(5):603-616. doi: 10.1002/osp4.596. eCollection 2022 Oct.

  • LeBlanc ES, Smith NX, Vesco KK, Hillier TA, Stevens VJ. Weight Loss Prior to Pregnancy and Early Gestational Glycemia: Prepare, a Randomized Clinical Trial. J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5001-e5010. doi: 10.1210/clinem/dgab547.

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Erin S LeBlanc, MD

    Center for Health Research, Kaiser Permanente Northwest

    PRINCIPAL INVESTIGATOR
  • Victor J Stevens, PhD

    Center for Health Research, Kaiser Permanente Northwest

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2015

First Posted

January 26, 2015

Study Start

June 1, 2015

Primary Completion

June 21, 2019

Study Completion

June 21, 2019

Last Updated

April 5, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Any information from this study we present in reports or publications will not identify any individual.

Locations